Latest prices for generic venetoclax/venetoclax
Venetoclax/Venetoclax (Venetoclax) is a targeted drug mainly used to treat specific types of hematological malignancies, especially chronic lymphocytic leukemia (CLL) and acute myeloid leukemia (AML). Venexaclava promotes the apoptosis of cancer cells by selectively inhibiting the function of B-cell lymphoma 2 (BCL-2) protein. BCL-2 is a protein that inhibits cell death and is overexpressed in many cancers, resulting in prolonged cell survival. Therefore, inhibiting the effects of BCL-2 can effectively help eliminate these cancer cells, thereby improving patient prognosis.
Venetoclax is usually used in patients whose disease has relapsed or is refractory despite other treatments. For patients with chronic lymphocytic leukemia, venetoclax has been shown to significantly improve progression-free survival and overall survival. Compared with traditional chemotherapy, this targeted therapy has relatively fewer side effects and is better tolerated, making it one of the important options for treating this type of disease.
As patents expire, more and more pharmaceutical companies are beginning to develop generic versions of venetoclax to provide more cost-effective treatment options. A generic drug is a drug that has the same active ingredients, dosage form, route of administration and effect as the original drug. It can reduce medication costs for patients without affecting the efficacy. The launch of generic drugs not only provides patients with more choices, but also helps alleviate the pressure on medical costs and improve the accessibility of drugs.
Currently in the overseas market, common manufacturers of generic venetoclax include Laos Pharmaceuticals (Lucius Pharmaceuticals, Daxiong Pharmaceuticals, ASEAN Pharmaceuticals), Bangladeshi pharmaceuticals (Ziskar Pharmaceuticals, Yaopin International, Everest Pharmaceuticals, Beacon Pharmaceuticals), etc. Each box may be sold for around 2-4,000 yuan (the price may fluctuate due to exchange rates), which is cheaper than the original drug.
Reference materials:https://en.wikipedia.org/wiki/Venetoclax
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)